Collected sera from patients with active (symptomatic) relapsing-remitting MS (RRMS) demonstrated a higher signature of demethylated MOG cfDNA when compared with patients with inactive disease and healthy controls. The gene discussed is MOG; the disease is relapsing-remitting multiple sclerosis.